Safety comes from quality

July 10, 2012

A new report on ADR (adverse drug reaction) made by Pharmacosmos shows an industry-low number of reported ADRs.

"In 12 years, Pharmacosmos has a reporting rate of ADRs of less than 0.00005%" says Lars Lykke Thomsen, Vice President & Chief Medical Officer .

This has to be measured up against the fact that Uniferon is now available in numerous countries around the world and is considered the injectable iron market leader.

"At Pharmacosmos, we take deep pride in our excellent track record, and we work diligently to maintain a high level of quality in all aspects concerning the product" says Lars Christensen, President & Chief Executive Officer.

Have a look at the journey behind each batch of Uniferon in the interactive Life Cycle animation here - and learn firsthand why safety comes from quality.

About Uniferon

Uniferon is a modern improved iron hydrogenated dextran based on a natural formula, which is approved for global use:

Uniferon is manufactured without the use of any organic solvents or cyanide, thus, avoiding trace residues of these impurities. Pharmacosmos manufactures iron dextran of high quality and unique purity for customers worldwide. Uniferon is the only injectable iron brand for piglets approved in the EU, the US and Asia.

About Pharmacosmos

Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use.

A research-based company, its ongoing R&D programme focuses on improving the lives of patients with iron deficiency with or without anaemia. More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. This makes it one of the largest global health challenges of our time.

Pharmacosmos has subsidiaries in the Nordics, the UK and the US and its products are marketed in more than 80 countries across the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.